Dicerna Pharmaceuticals Inc (DRNA) Stock Price, Quote, News and Overview

What is the stock price of Dicerna Pharmaceuticals Inc today?

The current stock price of DRNA is 38.22 null. The price increased by 0.58% in the last trading session.

What is the ticker symbol for Dicerna Pharmaceuticals Inc stock?

The exchange symbol of Dicerna Pharmaceuticals Inc is DRNA and it is listed on the Nasdaq exchange.

On which exchange is DRNA stock listed?

DRNA stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for Dicerna Pharmaceuticals Inc stock?

14 analysts have analysed DRNA and the average price target is 37.16 null. This implies a price decrease of -2.78% is expected in the next year compared to the current price of 38.22. Check the Dicerna Pharmaceuticals Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is Dicerna Pharmaceuticals Inc worth?

Dicerna Pharmaceuticals Inc (DRNA) has a market capitalization of 2.97B null. This makes DRNA a Mid Cap stock.

How many employees does Dicerna Pharmaceuticals Inc have?

Dicerna Pharmaceuticals Inc (DRNA) currently has 302 employees.

What are the support and resistance levels for Dicerna Pharmaceuticals Inc (DRNA) stock?

Dicerna Pharmaceuticals Inc (DRNA) has a support level at 38.04 and a resistance level at 38.26. Check the full technical report for a detailed analysis of DRNA support and resistance levels.

Is Dicerna Pharmaceuticals Inc (DRNA) expected to grow?

The Revenue of Dicerna Pharmaceuticals Inc (DRNA) is expected to decline by -6.12% in the next year. Check the estimates tab for more information on the DRNA EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy Dicerna Pharmaceuticals Inc (DRNA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of DRNA, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of DRNA, evaluating the profitability, health, valuation and growth aspects
• Dicerna Pharmaceuticals Inc (DRNA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Dicerna Pharmaceuticals Inc (DRNA) Sales and EPS estimates to see what analysts future expectations are.
• Dicerna Pharmaceuticals Inc (DRNA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Dicerna Pharmaceuticals Inc (DRNA) Insider and Institutional Ownership to learn about the owners and their transactions.
• Dicerna Pharmaceuticals Inc (DRNA) Stock Chart to make your own analysis
• Dicerna Pharmaceuticals Inc (DRNA) Latest news and press-releases to stay up to date.

Does Dicerna Pharmaceuticals Inc (DRNA) stock pay dividends?

DRNA does not pay a dividend.

When does Dicerna Pharmaceuticals Inc (DRNA) report earnings?

Dicerna Pharmaceuticals Inc (DRNA) will report earnings on 2022-03-04, after the market close.

What is the Price/Earnings (PE) ratio of Dicerna Pharmaceuticals Inc (DRNA)?

Dicerna Pharmaceuticals Inc (DRNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.63).

ChartMill assigns a fundamental rating of 3 / 10 to DRNA. DRNA has an average financial health and profitability rating.

Over the last trailing twelve months DRNA reported a non-GAAP Earnings per Share(EPS) of -1.63. The EPS decreased by -1.24% compared to the year before.

ChartMill assigns a Buy % Consensus number of 71% to DRNA. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of -13.03% and a revenue growth -6.12% for DRNA